IP Library Granted Patent US 7,425,320
Granted Patent B2
US 7,425,320 · App. 10/489,645 · Granted Sep 16, 2008

Use of guaiol for treating the skin

Assignee: Ciba Specialty Chemicals Corp
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,425,320
App. No.
10/489,645
Granted
Sep 16, 2008
Kind
B2
Abstract

The use is described of compositions comprising (a) (−)-guaiol, (b) further skin-lightening active substance(s) and, optionally, (c) one or more UV-A and/or UV-B absorbers as melanogenesis inhibitors and for skin-lightening.

Claims (41)

1. A method of inhibiting melanogenesis, which comprises contacting skin with an effective amount of a composition comprising

(a) (−)-guaiol which originates from Callitris intratropica and

(b) further skin-lightening active substance(s) selected from the group consisting of quercitin, aloesin, azelaic acid and esters thereof.

2. A method according to claim 1 , wherein the ratio of component (a):(b) is from 1:99 to 99:1% by weight of component (b).

3. A method according to claim 1 , wherein the composition additionally comprises, as component (c), one or more UV-A and/or UV-B absorbers.

4. A method according to claim 3 , wherein as UV-A and/or UV-B absorber there is used a compound of formula

wherein

R 1 and R 2 are each independently of the other C 3 -C 18 alkyl; C 2 -C 18 alkenyl; a radical of formula —CH 2 —CH(—OH)—CH 2 —O—T 1 ; or

R 1 and R 2 are a radical of formula

R 12 is a direct bond; a straight-chain or branched C 1 -C 4 alkylene radical or a radical of formula —C m 1 H 2m 1 — or —C m 1 H 2m 1 —O—;

R 13 , R 14 and R 15 are independently of the others C 1 -C 18 alkyl; C 1 -C 18 alkoxy or a radical of formula

R 16 is C 1 -C 5 alkyl;

m 1 and m 3 are each independently of the other from 1 to 4;

p 1 is 0 or a number from 1 to 5;

A 1 is a radical of formula

R 3 is hydrogen; C 1 -C 10 alkyl; —(CH 2 CHR 5 —O) n 1 —R 4 ; or a radical of formula —CH 2 —CH(—OH)—CH 2 —O—T 1 ;

R 4 is hydrogen; M; C 1 -C 5 alkyl; or a radical of formula —(CH 2 ) m 2 —O—T 1 ;

R 5 is hydrogen; or methyl;

T 1 is hydrogen; or C 1 -C 8 alkyl;

Q 1 is C 1 -C 18 alkyl;

M is a metal cation;

m 2 is from 1 to 4; and

n 1 is 1-16.

5. A method according to claim 4 , wherein the composition comprises, as component (c), the compound of formula

6. A method according to claim 1 , wherein the composition comprises, as component (c), the compound of formula

T 2 is C 1 -C 12 alkyl.

7. A method according to claim 6 , wherein T 2 is iso-octyl.

8. A method according to claim 1 , wherein the composition comprises, as component (c), octyl methoxycinnamate.

9. A method according to claim 1 , wherein the composition comprises, as component (c), benzophenone 3.

10. A method according to claim 1 whereby skin is lightened.

11. A method in which a composition according to claim 1 is incorporated into a cosmetic formulation.

12. A method according to claim 11 , wherein the composition is in the form of an oil-in-water formulation, in a solvent formulation or in the form of a paste formulation.

13. A method according to claim 11 , wherein the amount of the composition in the formulation is from 0.01% to 10% by weight.

14. A cosmetic formulation according to claim 11 comprising

(a) (−)-guaiol,

(b) further skin-lightening active substance(s) and, optionally,

(c) one or more UV-A and/or UV-B absorbers.

15. A cosmetic formulation according to claim 14 , comprising

(a) from 0.01 to 5% by weight of (−)-guaiol,

(b) from 0.01 to 5% by weight of further skin-lightening active substance(s) and, optionally,

(c) from 0 to 30% by weight of one or more UV-A and/or UV-B absorbers. 3

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 20, 2004
From: BASCHONG, WERNER; HEINEMANN, GERD; OCHS, DIETMAR
To: CIBA SPECIALTY CHEMICALS CORP.
Reel/Frame 016089/0508 →
Priority Claims (1)
EP 01810902 · Sep 18, 2001 · regional
Continuity (1)
Related Publication 20050058610A1 · Mar 17, 2005